3544 results for «2064»
3544 results
Refractory heart failure: combining oral therapy and device is key
21 May 2025 – From EuroPCR 2025
Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.
High-risk PCI in TAVI procedures
23 May 2025 – From EuroPCR 2025
This session highlights high-risk PCI in the context of TAVI procedures, including hybrid approaches for aortic stenosis with coronary disease, valve-in-valve scenarios, and unique anatomical challenges such as total situs inversus, emphasizing comprehensive patient management.
Out of the box: tackling complex peripheral intervention
23 May 2025 – From EuroPCR 2025
Explore unconventional approaches to complex peripheral interventions through case studies involving pulmonary arteriovenous malformations, splenic aneurysms, vascular complications post maxillofacial surgery, and cyanosis in structurally normal hearts, emphasizing diagnostic and therapeutic ingenuity.
Paravalvular leak closure in TMVR
23 May 2025 – From EuroPCR 2025
This session addresses paravalvular leak closure in transcatheter mitral valve replacement, exploring multiple plug techniques, complex leak management, and combined antegrade and retrograde approaches, providing nuanced insights into challenging mitral prosthesis complications.
Life threatening complications in CTO PCI
23 May 2025 – From EuroPCR 2025
Focus on life-threatening complications during CTO PCI with topics including rotational atherectomy challenges, interventricular septal puncture, surgical retrieval of fractured guidewires, and image-guided strategies for managing multivessel CTO complications, enhancing procedural safety.
Coronary complications: sharing the unusual ones
23 May 2025 – From EuroPCR 2025
This session shares unusual coronary complications including microcatheter tip entrapment, balloon shaft fracture, coronary balloon rupture salvage, and retained equipment retrieval, highlighting innovative solutions and procedural vigilance.
PCI for complex left main disease - LIVE Case
23 May 2025 – From EuroPCR 2025
An 82-year-old male patient with a history of STEMI and diagonal PCI (2004) presented with stable angina (CCS 2). CT imaging revealed 2 severe LAD stenoses (at the ostium and mid part), and a severe bifurcation stenosis at the Cx/OM1 confirmed by angiography. A staged PCI...
Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI
22 May 2025 – From EuroPCR 2025
Discover contemporary strategies integrating anatomy, physiology, and clinical judgment to guide percutaneous coronary intervention (PCI). This session explores the impact of stress cardiovascular magnetic resonance in primary prevention, viability-guided PCI, and physiology-based decision-making including quantitative flow ratio (QFR). Learn about identifying patients at risk for major...
TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation
22 May 2025 – From EuroPCR 2025
Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.
Acute complications during distal left main PCI - Part 1
22 May 2025 – From EuroPCR 2025
Navigate the challenges of acute complications during distal left main PCI with expert guidance. This session discusses troubleshooting techniques for stuck IVUS catheters, stepwise ostial LAD stenting, OCT applications when crush and kiss techniques fail, management of lost stents in heavily calcified bifurcations, and responses to...
Antiplatelet strategies for patients undergoing PCI
22 May 2025 – From EuroPCR 2025
Delve into this comprehensive session focusing on antiplatelet strategies for patients undergoing PCI. Explore evidence and clinical insights on ticagrelor monotherapy post-AMI stenting, shortened dual antiplatelet therapy (DAPT) durations, the role of CYP2C19 genotyping in stent thrombosis risk, the effectiveness of dual antithrombotic therapy in atrial...
Coronary complications: perforation and dissection
22 May 2025 – From EuroPCR 2025
Examine the unpredictable nature of coronary complications such as perforation and dissection during PCI. This session presents real-world cases illustrating sequential complications, their management challenges, and strategies to simplify complex scenarios. Understand how to anticipate, recognize, and effectively respond to these critical incidents to improve procedural...
Radiation protection: the good and the bad
22 May 2025 – From EuroPCR 2025
This session provides essential guidance on radiation protection in the cath lab. Learn practical steps to minimize radiation exposure for yourself and your team, manage the ergonomic challenges of protective gear, and develop skills to foster a culture of radiation safety within your workplace. Understand the...
LV support for very high risk PCI of calficied lesions
22 May 2025 – From EuroPCR 2025
Discover the role of left ventricular (LV) support in performing very high-risk PCI on heavily calcified lesions. This session highlights techniques for navigating complex calcified coronary anatomies using Impella support, strategies for metal casing reshaping, and management of acute MI and cardiac arrest scenarios. Explore alternative...
Managing ischaemic and bleeding risk of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Gain valuable insights into managing ischemic and bleeding risks in NSTEMI patients. This session reviews optimal timing for invasive strategies, variability in care processes, radial access approaches, and innovative antithrombotic strategies such as aspirin omission and prasugrel monotherapy to minimize bleeding while optimizing outcomes.
Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?
22 May 2025 – From EuroPCR 2025
Explore the evolving landscape of catheter-directed therapy for intermediate-high and high-risk pulmonary embolism. This session covers patient selection criteria, clinical signs indicating the need for intervention, management of potential complications, and ongoing studies shaping future treatments. Case-based discussions illustrate practical applications and key learnings.
PCI for complex calcific coronary artery disease - LIVE Case
22 May 2025 – From EuroPCR 2025
An 87-year-old female patient, at high bleeding risk and with preserved LV function, presented 2 months ago with an inferior STEMI and multivessel disease. She initially underwent RCA PCI followed by staged LCx PCI. She was now referred for PCI of a long, heavily calcified lesion...
Optimised patient selection for carotid artery stenting
22 May 2025 – From EuroPCR 2025
Optimize patient selection for carotid artery stenting with this session that highlights personalized approaches to ischaemic stroke treatment. Review bioactive stents versus endovascular therapy, feasibility and outcomes in near-occlusion cases, and long-term retrospective analyses supporting carotid stenting as a strategic ally in embolic stroke management.
Contemporary outcomes of PCI patients
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.
Updates on percutaneous treatment of pulmonary embolism
22 May 2025 – From EuroPCR 2025
Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.
